- Report
- December 2025
- 227 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 380 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 221 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 242 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 475 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- October 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- December 2025
- 166 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 278 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- October 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- September 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- July 2025
- 175 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- August 2025
- 150 Pages
Global
From €2959EUR$3,358USD£2,599GBP
€3481EUR$3,950USD£3,057GBP
- Report
- March 2025
- 87 Pages
Global
From €3500EUR$4,255USD£3,182GBP
- Report
- September 2025
- 480 Pages
Global
From €3172EUR$3,600USD£2,786GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5243EUR$5,950USD£4,605GBP
- Report
- August 2025
- 120 Pages
United States
From €5243EUR$5,950USD£4,605GBP
- Report
- July 2025
- 200 Pages
United States
From €2194EUR$2,490USD£1,927GBP
- Report
- March 2023
- 174 Pages
Global
From €1673EUR$1,899USD£1,470GBP
- Report
- September 2023
Global
From €4362EUR$4,950USD£3,831GBP
- Report
- April 2024
- 120 Pages
Global
From €5243EUR$5,950USD£4,605GBP

The mRNA Therapeutics market is a subset of the larger Genomics market, which focuses on the development of therapeutics based on messenger RNA (mRNA). mRNA is a type of genetic material that is used to produce proteins in cells. mRNA Therapeutics are designed to target specific diseases by delivering mRNA molecules to cells, which can then be used to produce proteins that can treat or prevent the disease. mRNA Therapeutics have the potential to revolutionize the way diseases are treated, as they can be used to target specific diseases without affecting other parts of the body.
The mRNA Therapeutics market is still in its early stages, but is expected to grow rapidly in the coming years. Companies in the market are focused on developing mRNA-based therapeutics for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders.
Some of the companies in the mRNA Therapeutics market include Moderna, CureVac, Arcturus Therapeutics, and BioNTech. Show Less Read more